gastric emptying glp-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These The effect of different GLP-1

In addition, exenatide was shown to activate GLP-1R and inhibit the PI3K/AKT pathway to inhibit the growth, migration, and invasion of ovarian cancer cells, and promote cell apoptosis, thereby producing anticancer effects on diabetic patients with ovarian cancer (218)

USADA BPC-157 is een experimenteel peptide en verboden voor atleten in competitieverband

It can also help with dullness and dark spots

Figure 2: Pathogenesis of type 1 and type 2 diabetes

With EnGuide Pharmacy, eligible members have access to an enhanced clinical service model tailored to their needs

Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and supports weight management when combined with lifestyle changes